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ABSTRACT 
 
 
 
Program “Via Verde do AVC”  
Analysis of the Impact on Stroke Mortality 
 
 
Sara Sofia Silvestre Silva 
 
 
 
Introduction: Stroke – a cardiovascular disease caused by the interruption of the blood 
supply to the brain – is the 3rd cause the death in the World, and the 1st in Portugal.  
Aware of this burden, the program ‘Via Verde do AVC’ was implemented in Portugal, with 
the objective of reducing mortality by stroke, specially on ischemic stroke patients aged 
between 18 and 80 years old.  
 
Objectives: This thesis focus on the performance of ‘Via Verde do AVC’, and aims to 
assess whether the program has achieved significant health gains, at reasonable costs. 
 
Methodology: Individual level in-hospital data on stroke admissions, and regional level 
stroke mortality rates are studied, in order to assess the program’s impact on mortality. For 
in-hospital analysis, the impact is measured as a whole, as well as breakdown by expertise 
level and/or year. In the regional analysis, simple and weighted regressions are performed. 
Results: The regressions performed do not show statistically significant impact of ‘Via 
Verde do AVC’ on ischemic stroke mortality. The health status of the patient at arrival 
(measured by the number of diagnosis), as well as the hospital are the most relevant 
explanatory variables. For regional analysis, there are significant regional asymmetries in 
stroke mortality, and time has also been a critical factor for mortality reduction. 
 
Conclusions: There is little reason to believe that the program decreases mortality before 
or during a hospital stroke episode. Moreover, there are some aspects of the program that 
should be improved, namely Promotion, Training, and Post-hospital Care. 
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WORD LIST 
 
 
 
ACS  Alto Comissariado da Saúde (High Commissariat for Health) 
ARS  Administração Regional de Saúde (Health Regional Administration) 
AVC  Acidente Vascular Cerebral (Stroke) 
CNDCV  Coordenação Nacional para as Doenças Cardiovasculares (National 
Coordination for Cardiovascular Diseases) 
CODU  Centro de Orientação de Doentes Urgentes (Orientation Center for 
Emergency Patients) 
CVD  Cardiovascular Diseases 
INE  Instituto Nacional de Estatística (National Institute of Statistics) 
INEM  Instituto Nacional de Emergência Médica (National Institute of Medical 
Emergency) 
IT  Information Tecnologies 
NIHSS  National Institutes of Health Stroke Scale 
NINDS  National Institute of Neurological Disorders and Stroke 
QALY Quality-adjusted Life Years 
rt-PA  Recombinant Tissue Plasminogen Activator 
WHO  World Health Organization 
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I. INTRODUCTION 
 
1. Health Economics – A growing field of research 
The Health Care sector, both for its increasing importance in society and peculiar 
characteristics, has been subject to a great deal of attention from various fields of research, 
and Economics is no exception. 
Graph 1 – WHO Data Repository 
Indeed, in the developed world, this sector is already responsible for approximately 
10% of GDP - and the prediction is that this share will continue rising, pressured by 
technological advances, population aging and rising public expectations (Huber & Orosz, 2003). 
Besides its economic importance, there are also a vast number of characteristics in the 
health care sector that make it different from any other.  
Probably the most distinct one is the fact that access to health care services is 
considered an universal right in many countries  which often calls for a strong role of the 
State in the system (Weaver & al., 2010). In Portugal, in particular, the Government is 
responsible for health care regulation, financing, ownership, payment and provision.  
Graph 2 – WHO Data Repository 
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In consequence, the Health Care sector is tendentially  a non-profit one,  and in most 
cases, patients and health care providers are not the ones paying for the service – and 
research has shown that, in such context, utilization of resources tend to be excessive and 
the economic principles of welfare optimization are not achieved. 
Overall, this sector presents a complex and unique environment from an economic 
perspective. In particular, as health care expenses increase - and because the Government is 
the major payer -, tax raises, cost cuts in other areas and out-of-pocket contributions 
increases will be unavoidable (Watson, 2006). However, as research has shown (Anderson & 
Frogner, 2008), it is not obvious that higher costs bring additional health benefits. 
Consequently, the optimization of processes - through better allocation strategies at clinical, 
organizational and public policy levels - should constitute a major goal in the Health Care 
sector, as it maximizes the benefits achieved from the use of limited medical resources 
(Crowe, 2010). 
 
2. The Research Topic 
This work delves into the intersection of Health and Economics, assessing whether 
process optimization can be a complement of technological innovation. More specifically, it 
focus on the case of ‘Via Verde do AVC’, a program that intends to reduce stroke mortality in 
Portugal, by introducing significant changes in the process followed by stroke patients – 
including pre-hospital, in-hospital and post-hospital procedures.  
In short, this work aims to assess whether the program ‘Via Verde do AVC’ has 
achieved significant health gains, at reasonable costs. In order to reach this conclusion, 
several questions must be answered, namely: 
1. Was the program responsible for statistically significant health gains?  
2. If health gains are statistically significant, what were the costs involved?  
2.1. Were the health gains achieved at reasonable costs? 
3. If health gains are not statistically significant, what might be the reasons for such 
result? 
In this thesis, these questions will be answered by studying individual level in-patient 
hospital data on stroke admissions and by studying regional level stroke mortality rates. 
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3. Stroke  
According to World Health Organization, a stroke is a cardiovascular disease (CVD) 
«caused by the interruption of the blood supply to the brain, usually because a blood vessel 
bursts [hemorrhagic stroke] or is blocked by a clot [ischemic stroke]. This cuts off the supply 
of oxygen and nutrients, causing damage to the brain tissue.» The most common symptom is 
sudden weakness or numbness of the face, arm or leg, but it can also be preceded by 
confusion, difficulty speaking, severe headache, fainting or unconsciousness. Depending on 
the degree of severity, it can cause immediate death. 
The most relevant risk factors for stroke are tobacco smoking, poor physical activity 
and unhealthy diet. It is uncommon in people under 40 years, but in those cases it is mainly 
due to high blood pressure. (WHO, 2011) 
There are 15 million people suffering from stroke every year – a trend that is expected 
to hold in the future. Of those, 5.5 million die and other 5 million are left permanently 
disable. It is the 3rd cause the death in the World (10%), only exceeded by coronary heart 
disease (13%) and cancer (12%) (Mackay & Mensah, 2004). 
Also in Portugal, Cardiovascular Diseases are the number one cause of death, 
responsible for almost 40% of mortality (INE, 2010). Of those, approximately 45% are caused 
by stroke. In 2004, the standardized mortality by stroke was 97,6/100.000 inhabitants, with 
great regional asymmetries. (ACS; CNDCV, 2007)  
Aware of the worldwide pressure towards government investments on stroke 
prevention and control programs (WHO, 2011), in Portugal, the National Health Plan and the 
National Program for Prevention and Control of CVD have defined specific strategies and 
targets to reduce both the standardized mortality rate, in particular for people below 65 
years old, and in-hospital mortality by stroke (ACS; CNDCV, 2007). In order to achieve these 
targets, the program ‘Via Verde do AVC’ was developed and it has been implemented across 
the country since 2005. 
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4. Academic and Managerial Relevance 
Given the high mortality rate associated with stroke in Portugal, the national coverage 
of the program and the significant level of resources devoted to it, it is academic and 
politically interesting to assess the real impact of such measures. Indeed, mortality rates 
from stroke have been decreasing in the last years, and some claim that ‘Via Verde do AVC’  
played an  important role of achieving  those results. Nevertheless, no rigorous studies have 
been done so far in order to prove this link.  
   
 
Target vs. Actual Mortality: 2003-2009 
 
Graph 3 – (ACS, 2010) 
 
Additionally, on an economic and managerial perspective, more than simply assessing 
the gains, it is of extreme importance to include the ‘cost-side’ of the project, in order to  
measure the trade-off between resources allocated and gains achieved – showing a more 
complete, informative, and comparable perspective, one that better supports the decision-
making process. 
Finally, the research also intends to present a critical analysis of the program design 
and implementation. The identification of its strengths - as well as its shortfalls - can be of 
«Stroke mortality has decreased 33,8% [between 2000-2008]. Maria do Céu Machado [ex-High-
Commissioner+ says this is the proof that “a regionally well planed and implemented intervention 
delivers significant gains. There was strategic, multidisciplinary planning, bringing together INEM, 
hospitals, and campaigns to increase populations' literacy”» 
 
In Público, (22-09-2011), p. 10 
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great relevant in practical terms, as it will allow the replication of best practices and the 
correction of problems. 
 
In the next chapter, the details of the design and implementation of the Program “Via 
Verde do AVC” are briefly described, followed by a chapter that gives important background 
information concerning stroke programs that have been implemented worldwide, and which 
have goals similar to those established in Portugal; the chapter also presents some relevant 
results of research about the impact of such programs. 
The forth chapter delves into the description of the Methods and Data used in order to 
perform the analysis of in-hospital mortality, as well as regional mortality. In the fifth 
chapter, the results obtained in the statistical analysis are presented; moreover, a critical 
analysis of the program’s design and implementation is included, in an attempt to better 
understand the results obtained. 
Conclusions are drawn in the last chapter, summarizing the problem analyzed and the 
results of the analysis carried out, and highlighting some limitations of this work and 
suggestions for further research. 
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II. DESCRIPTION OF  ‘VIA VERDE DO AVC’ 
 
Despite the efforts devoted to the development of more effective medicines (Grotta & 
al., 2008), intravenous rt-PA (recombinant tissue plasminogen activator) is the only approved 
treatment for stroke; it is only effective for acute ischemia – responsible for 80% of the total 
stroke episodes -, and cannot be administered in case of hemorrhagic stroke. rt-PA is used 
for arterial recanalization (destroying the clot that blocks the brain’s blood supply, inhibiting 
the evolution of the brain lesions, thus reducing the severity of the consequences), but can 
only be used within 3 hours after the beginning of the symptoms.  
For this reason – and given the fact that up to 70% of mortality by stroke occurs before 
arrival to the hospital (Gomes, 2007) –, it is critical to invest not only in scientific and technical 
progress, but also in improved organizational systems, in which healthcare resources are 
organized efficiently, and treatments are applied correctly (Leciñana-Cases & al., 2009). In line 
with that, ‘Via Verde do AVC’ is aimed to improve the patients’ accessibility to medical care, 
allowing a faster and more adequate treatment, and a consequent reduction of mortality. In 
order to do it, the entire process followed by patients - from the beginning of the symptoms 
until the rehabilitation stage - was redesigned, leading to significant changes in the 
organization, coordination and interaction of the various services and human resources 
involved. Via Verde applied only to patients 18 or older and up to 80 years old.   
 
Pre-hospital Stage – The process is initiated by a phone call to the emergency 
number (112) – so, the population cooperation and awareness are essential. In case of 
symptoms of stroke, the call is redirected to a local and specialized call center (CODU), that 
coordinates the operations until the arrival of the patient to the hospital: it allocates INEM 
resources for that emergency, determines the most suitable hospital of destination, and 
informs the medical team of that hospital of the eminent arrival of a stroke patient.  
 
In-hospital Stage – When arrived at the hospital, there is a team already in place 
waiting for the patient. A battery of exams is done, in order to confirm the diagnosis of acute 
ischemic stroke (rather than hemorrhagic stroke), and certify that the patient fulfills all the 
medical requirements for rt-PA administration. Once these procedures are completed, and 
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in case the requirements are met, the treatment starts – but only if less than 3 hours have 
passed since the beginning of the symptoms. 
 
Post-hospital Stage / Rehabilitation – For those who survive but are not fully 
recovered from the stroke episode, there is a net of rehabilitation services, intended to 
provide assistance to the patients after the in-hospital period. It includes four services: 
outpatient visits, physical therapy, social assistance, and home assistance. Although this 
stage is included in the Program’s guidelines, its implementation is not yet fully 
accomplished. 
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III. LITERATURE REVIEW 
 
 
1. Organizational Changes and Health Outcomes 
In response to an upward trend of stroke incidence worldwide, many countries (such 
as USA, Denmark, Spain and Netherlands) have already introduced stroke programs. 
Although adjusted to local needs, all of them have required organizational changes and 
improvements in the healthcare network involved in the process. 
First of all, it is critical to have emergency medical services capable of providing a quick 
identification of the acute health problems, pre-hospital notification and timely transport of 
patients to the hospital. In Montana - USA, for instance, investments have been made in 
educational programs to increase awareness of procedures for initial assessment (warning 
signs, recognition and triage of stroke patients), acute treatment, and transport of potential 
stroke patients - and positive results have been achieved (Oser, 2010). 
Intra-hospital changes have also been introduced during the last decade, and American 
studies present some interesting conclusions. Aimed to reduce delays in medical response, 
IT solutions enhancing communication, immediate access to information and decision 
support have been implemented. Time intervals from patients' arrival to intravenous 
thrombolysis were significantly reduced, while the number of patients who were treated 
with rt-PA increased. It also eliminated the previously detected negative relationship 
between onset-to-door time and door-to-needle time (on average, every 25-min earlier 
arrival was associated with a 15-min increase in time to initiation of rt-PA therapy). 
Nevertheless, these changes, alone, have not attained significant health gains ((Heo & al., 
2010), (Nam & al., 2007)). Similar programs have also been adopted to improve response time of 
in-hospital strokes, since they require, in general, greater time to be recognized than those 
from emergency (Cumbler & al., 2010). Moreover, patient risk stratification and implementation 
of best practice guidelines has led to a decreasing variation in stroke care delivery (Kavanagh & 
al., 2006).    
More significant change in health outcomes has been achieved by programs with 
broader scope, which is the case of Spain. Organizational changes in both pre and intra-
hospital stages, analyzed through time, have translated not only in more patients treated 
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with rt-PA, but also in a significantly larger percentage of patients who achieve functional 
independence after 3 months (Simal & al., 2009).  
Another important aspect is the post-hospital stage of stroke, as rehabilitation can also 
delivers significant health gains for stroke patients. The most relevant advantages of a 
treatment in dedicated rehabilitation units are shorter admission times, greater gain of 
independence, improvement in quality of life and greater probability of home discharge 
(Carod-Artal & al., 2005). However, there is less consensus about the ideal timing of the transfer. 
Most skeptics point out that early admission (and so early discharge from hospital) is an 
indicator (and not a cause) of the patient’s better condition. Indeed, there is evidence that 
moderately affected patients at admission will show significantly higher functional gains 
than severely affected patients at admission (Inouye & al., 2001), and that a few weeks 
difference in the admission time, once initial condition is controlled for, translate into non-
significant difference in health status  (Gagnon & al., 2006). Nevertheless, when considering 
large differences in the admission time, the functional improvements are significantly better 
for patients with earlier treatment (Carod-Artal & al., 2005). 
A final consideration should be made concerning prevention. Since stroke presents a 
high recurrence rate among survivors, and most of its risk factors can be modified, attention 
has been given to recurrence prevention programs that facilitate the initiation and 
maintenance of prevention measures, in the pursue of improved long-term treatment rates 
and quality of life. Research shows significant improvement in treatment utilization rates at 
discharge, as well as after 3 months and 1 year. Moreover, there is also evidence of a 
decrease in the occurrence of unfavorable clinical outcomes (Ovbiagele B. , 2008).  
 
2. Risk Factors and Mortality Rates 
Several factors are known to be related to stroke, so, in order to better understand the 
relevance of each of them in terms of health outcomes, prediction models have been 
developed. Such predictions are particularly useful for patient management and resource 
allocation (Counsell & al., 2002), for prognostic information for family members, as well as for 
health policy design and monitoring (Smith & al., 2010). 
For these prediction models to be useful and widely applicable in actual practice, they 
need to  be as simple as possible, address questions of practical importance, and to be based 
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on readily available information – nevertheless, current models are still too complex (Wang & 
al., 2000).  
The most commonly mentioned risk factors are age, gender, and previous history of 
atrial fibrillation and stroke; Smith & al. also mentions mode and hour of arrival, coronary 
artery disease, diabetes mellitus, hypertension, and functional status expressed by National 
Institutes of Health Stroke Scale (NIHSS); Wang & al. includes consciousness, incontinence, 
admission body temperature, and hyperglycemia without a clinical history of diabetes; 
Counsell & al. considers that living alone, independence before stroke, arm power and ability 
to walk and talk are the most relevant aspects. 
 
3. Functional Status and Cost-effectiveness Analysis 
Along with mortality, the degree of disability is also very relevant in stroke episodes. In 
order to track changes in the functional status of patients from the onset through discharge 
and follow-up, both in hospital and in rehabilitation, there was the need to develop a 
comprehensive, reliable and standardized tool that provided medical services with 
information on each specific case (Chumney & al., 2010). In response to this need, neurological 
examination guidelines, along with functional scales summarizing the examination, have 
been developed worldwide. However, great variety of evaluation methods and scales, low 
levels of inter-rater agreement due to subjective interpretation (Wilson & al., 2002), and poor 
or inexistent validity and reliability of such methods (Lyden & Lau, 1991) have hindered the 
acceptance of an ideal measure, so that there is, until nowadays, little consensus among 
experts on this topic (Gocan & Fisher, 2008).  
Despite their drawbacks, functional scales are still the most accurate measure of 
changes in stroke health status. Consequently, their uses have enlarged through time, and 
they have become particularly relevant in economic analysis. The most common use has 
been for health outcome prediction – and although they should not be seen as a sole 
explanatory variable (Muir & al., 1996), research shows that they can accurately predict 
mortality and recovery (Weimar & al., 2004).  
Moreover, they are also used in cost-effectiveness analysis. Given the fact that, in 
general, Quality-Adjusted Life-Years (QALYs) are the economic measure used to express the 
health gains in these analysis, researchers have tried to establish a link between stroke 
scales and economic utilities. The findings indicate that different study populations (stroke 
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survivors, at risk, healthy) and elicitation methods (Standard Gamble, Time Trade-Off, etc.) 
lead to different perceptions of utility. Also here, diversity in the definition of each functional 
status is the main cause of such variation (Post & al., 2001). 
 
Some cost-effectiveness studies have been carried out worldwide. In the USA, research 
shows incremental cost savings per QALY gained with rt-PA treatment; compliance with 
NINDS (National Institute of Neurological Disorders and Stroke) recommendations for care of 
stroke patients translated into greater QALY value for rt-PA treatment, with cost savings 
from reduced hospital, rehabilitation and nursing home costs. Moreover, implementation of 
a specialized stroke program was associated with declining average cost of treating stroke 
patients and with lower average length-of-stay (Demaerschalk & al., 2010).  
Similar outcomes have been achieved in Europe. It was estimated that the 
implementation of a system similar to ‘Via Verde do AVC’ in Spain would result in cost-
savings, while avoiding deaths and dependencies (Leciñana-Cases & al., 2009). In Netherlands, 
the life-time effectiveness of a stroke service (an integration of a hospital stroke unit with 
nursing homes, rehabilitation centers, and home care providers) translated into cost savings 
(from shorter mean length of stay in hospital, and lower proportion of patients 
institutionalized after stroke), while generating more QALYs (Baeten & al., 2010). Similar long-
term results were achieved in Denmark with the introduction of rt-PA, due to savings in 
rehabilitation, nurse homes and re-hospitalization, despite the short-run increase of 
economic costs (Ehlers & al., 2007). 
In short, it can be said that, when properly planned and implemented, organizational 
change can, indeed, facilitate and support scientific advances, achieving both health gains 
and cost savings. It is then relevant to understand whether this is also the case in Portugal.  
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IV. DATA COLLECTION AND METHODOLOGY 
 
 
1. In-hospital Mortality 
1.1. Data Sources and Criteria 
For this analysis, the clinical information regarding stroke patients from ARS Norte and 
ARS Algarve is considered, since these were the only two regions (among the existent 5) 
where there was complete data concerning the date of the beginning of Via Verde do AVC in 
all the regions’ hospitals. 
The clinical information of stroke episodes was collected from the GDH (Grupos de 
Diagnóstico Homogéneos – Diagnosis Related Groups (DRG)) databases. The time frame 
considered goes from 2004 to 2009, since Via Verde do AVC was implemented for the first 
time in 2005. The GDH databases include almost all in-patient episodes in NHS hospitals, and 
the data on each episode include age, sex, date of admission, date of discharge and 
discharge status, the DRG and up to 20 diagnoses codes from the International Classification 
of Diseases, version 9 Clinically Modified (ICD 9 CM).  
Data on the starting date of the program in each of the relevant hospitals was 
collected on official reports and press releases published by ARS Norte and ARS Algarve (as 
presented on Appendix 1).  
Before starting the analysis itself, it was necessary to filter and organize the data. 
Based on the opinion of medical experts, the relevant episodes were selected based on 
the 1st diagnosis (ICD 9 CM), rather than on the GDH reported. Both ischemic stroke (code 
433 and 434) and hemorrhagic stroke (code 430, 431 and 432) were kept on the sample - 
despite the fact that only the first was targeted on the program -, so that a more complete 
analysis can be performed, on whether the program has also had an impact on hemorrhagic 
stroke patients.  
Episodes from ARS’s other than Norte (code 1) and Algarve (code 5) were removed 
from the sample. Observations in which it was not possible to determine whether the 
patient survived or not, due to transfers (code dsp=2) or lack of information (code dsp=99) 
were also eliminated. 
Variables’ names were standardized throughout the various databases, so that they 
were comparable once merged. 
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Moreover, as the hospital identification in 2009 had a different coding from the 
previous years, it was necessary to carefully analyze and compare the data in order to match 
the observations. This match was performed according to: 1. volume of episodes; 2. covered 
regions by hospital; 3. hospital of destination by region. The matched ID codes are presented 
on Appendix 1.  
 
1.2. Methodology 
Some Statistics based on GDH’s data were computed before performing the actual 
analysis of effectiveness, in order to have some insights on the sample’s trends across time, 
regions and demographics, as well as mortality patterns.  
 
Regression analysis was performed with Stata 10, using a logistic function.  
Besides the variables presented in the GDH databases, some others needed to be 
generated. 
1. DMort: dummy variable, referring the final outcome of the patient. Value ‘1’ 
represents ‘Dead’ (code dsp=20), and value ‘0’ represents ‘Alive’ (remaining cases).  
2. Nddx: numerical variable, counting the number of diagnosis. It ranges from 1 (only 
stroke diagnosis) to 20 (stroke and 19 other diagnosis).  
3. age2: numerical variable, it is the age squared. It attempts to capture non-linear 
effects of age on mortality 
5. age3: numerical variable, it is the age cubic. It attempts to capture non-linear effects 
of age on mortality. 
6. isch: dummy variable, referring the type of stroke the patient had. Value ‘1’ 
represents ‘Ischemic stroke’ (code 433 and 434), and value ‘0’ represents ‘Hemorrhagic 
stroke’ (remaining cases). 
4. VV: dummy variable, referring the existence of Via Verde do AVC. It captures the 
overall effect of the program on mortality. Value ‘1’ represents ‘Existence of VV-AVC’ 
(ent1>= date of beginning of the program in a specified hospital), and value ‘0’ represents 
‘Non Existence of VV-AVC’ (remaining cases) 
5. VV1 – VV5: dummy variables (5), referring the longevity of the program in each 
hospital. VVk  equals “1” for the observations that occurred within the kth *k Є {1;5}] year of 
the program in the specific hospital, and 0 otherwise. These variables capture the effect of 
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expertise (through the practice acquired with Via Verde do AVC) on mortality. In line with 
findings from studies already mentioned, it is expectable that, the longer the existence of 
the program, the better the system performs, which ultimately translates into a greater 
impact on clinical outcomes.  
1.  VV05 – VV09: dummy variables (5), referring the existence of Via Verde do AVC in a 
given year. VVk  equals “1” for the observations that occurred in the year 20k *k Є 
(05;09)], in an hospital with VV AVC. They capture the effect of Via Verde do AVC in a 
specific year – the more people are aware, prone and able to use the program, the 
greater the impact it can attain in the overall. However, since this process of change 
is generally slow, it is predictable that, as time passes, the program enlarges its 
coverage and, consequently, the average impact on the target population increases. 
2. VV05_1 – VV09_5: dummy variables (15), referring the longevity of the program for 
each hospital, in a given year. VVk_j equals “1” for the observations that occurred in the year 
20k [k Є (05;09)], in a hospital in which the program is in its jth *j Є (1;5)+ year of 
implementation. These variables combine the effects captured by the previous two: the 
impact that different stages of longevity/ expertise, as well as the passage of time have on 
the effectiveness of Via Verde do AVC.  
 
 The variables considered are: 
 
 Table 1 – Variables included on In-hospital regression analysis 
 
  
Variables Range Source Comments Info Category 
Mortality {0;1} GDH Dependent Variable 
Clinical 
Outcome 
Age ]18;80[ GDH Linear? Include Age2 and Age3 
Demographics 
Gender {0;1} GDH - 
N. of 
Diagnosis 
{1;20} GDH - Clinical History 
Hospital {0;1} GDH - 
Expertise 
Year {0;1} GDH - 
Via Verde 
AVC 
{0;1} 
ARS1; ARS5; 
Health Portal 
Date of implementation by Hospital. 
Overall effect; breakdown by year or/ and 
time since implementation  
Intervention 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
15 | P a g e  
 
The regression analysis performed included age, gender, number of diagnoses, hospital 
and year dummy variables, and limited the sample to the ischemic stroke patients with age 
higher than 18 and lower than 80 years old.   
However, some variations were tried in order to better predict the program’s impact: 
- The overall impact of Via Verde do AVC: measured by a single VV variable 
o The base case: ischemic stroke patients 
o Restricting the geographic area of the sample (ARS Norte) 
o Restricting the number of diagnosis of the sample (Nddx=1) 
o Restricting to non-target patients (hemorrhagic stroke patients, aged 
]18;80[) 
- The breakdown impact of Via Verde do AVC 
o By Expertise: measured by VV1 – VV5 variables 
o By Year: measured by VV05 – VV09 variables 
o By Expertise and Year: measured by VV06_1 – VV09_5 variables 
 
2. Regional Mortality 
2.1. Data Sources and Criteria 
While in the analysis of in-hospital mortality each observation corresponds to a single 
stroke episode, and only the episodes treated in an hospital are considered, the regional 
analysis is based on regionally aggregated data, taking into account all the cases in which 
stroke was stated as being the cause of death. Moreover, while in the previous approach, 
the clinical outcome was survival or death (of stroke patients), in this case the outcome is a 
mortality rate (by stroke, per 100.000 inhabitants). 
This analysis is limited to ARS Norte’ region, since this was the only ARS for which it 
was possible to find detailed information concerning stroke mortality through time and by 
region. The data concerning stroke mortality (standardized mortality rate – SMR – and gross 
mortality rate – GMR) by region, year, gender and age group was made available by ARS 
Norte. The primary source of data is INE, and Public Health Department of ARS Norte 
performs the treatment of this data. Given the fact that SMR already controls for the 
demographics in each region, this was the chosen variable to measure mortality, and data on 
age groups and gender were not used as covariates in the analysis. It was not possible to 
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limit the analysis to the program’s target population that is to ischemic strokes in the 18 to 
80 population, so all deaths by cerebrovascular diseases, for all ages, were included. The 
time frame considered was from 2001 to 2009. 
Data on population by region through time was collected from INE databases. The 
information previously collected concerning the starting date of Via Verde do AVC in each 
hospital was also used for this analysis. 
Since ARS Norte data was organized by pre-defined regions, INE data on population 
was organized by “concelhos”, and data on starting date of the program referred to 
hospitals, it was necessary to standardize all the information into a unique criteria – ARS 
Norte regions were chosen as the standard. 
Information on “concelhos” that compose each of the 24 ARS Norte regions was 
collected in ARS Norte Portal. Based on this match (region/”concelhos”), INE data on 
population by “concelhos” was grouped into population by ARS Norte regions. 
Moreover, data on covered “concelhos” by hospital was found in the Health Portal. 
Since each hospital’s covered areas perfectly (or almost perfectly) fit to ARS Norte regions, it 
was possible to match hospitals tp regions  and thus determine the starting date of "Via 
Verde do AVC" in each region. It is also relevant to mention that the information on 
“concelhos” covered by each hospital (based on Health Portal’s data) was compared to the 
actual origin of patients in each hospital (based on GDH data) and, indeed, they match the 
large majority of the observations (the majority of patients from a given “concelho” are 
actually treated in the hospital that covers that area), so that it is reasonable to assume the 
link between region/hospital used in thie analysis.  
A table resuming the match hospital /”concelhos”/ region is presented on Appendix 2. 
 
2.2. Methodology 
Regression analysis was performed with Stata 10, using multiple  linear regression.  
Besides the collected variables, a dummy variable VV was created. It refers to the 
existence of "Via Verde do AVC". VV is equal to “1” for observations that occurred in a year 
and region in which there is Via Verde do AVC. For the year of implementation of the 
program in a given hospital/ region, VV equals “1” only if such implementation occurred 
before June 30th (more than half a year with Via Verde do AVC). Value ‘0’ represents ‘Non 
Existence of VV-AVC’ (remaining cases).  
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Moreover, and in line with what was done with in-hospital data, the impact of the 
program was broken down by expertise level (VV1 – VV5), year of the observation (VV05 – 
VV09) and both (VV05_1 – VV09_5). However, since the results of this analysis did not differ 
considerably from the simplest approach, they are not presented in this work.  
So, the variables considered were: 
 Table 2 – Variables included on Regional regression analysis 
 
 The analysis was then performed using two different approaches: 
-  Simple linear regression 
-  Linear regression weighted by regional population 
 
 
 
Variables Range Source Comments Info Category 
SMR rate ARS Norte Dependent Variable Clinical Outcome 
Region {0;1} ARS Norte 24 regions 
Expertise 
Year {0;1} - 2001-2009 
Population - INE - Weight 
Via Verde 
AVC 
{0;1} ARS Norte 
Date of implementation by Hospital/ 
region 
Intervention 
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V. RESULTS ANALYSIS 
 
 
1. Statistics 
1.1. Programs’ Coverage Potential 
After the information has been filtered and properly organized, the database was 
composed by 51.603 observations. Excluding hemorrhagic stroke episodes (ICD9 CM codes 
430, 431 and 432)  , the number of observations reduces to 43.807, a 15% reduction.  
Among episodes of ischemic stroke, data was excluded even further, in order to 
contain only those cases which met the age criteria of the program: more than 18 years and 
less than 80. At this point, only 28.842 episodes were eligible to the activation of "Via Verde 
do AVC" – which represents approximately 56% of the total number of stroke episodes 
during the period of 2004-2009.  
 
Graph 4 – Program’s Coverage Potential 
 
1.2. Characteristics of Ischemic Stroke Patients  
93% of the observations used in the sample are from ARS Norte. Among these, the 
distribution in terms of hospital of destination is fairly uneven, with Hospital de S. João 
receiving 14% of the patients, while some others have almost 0% (Espinho, IPO Porto). On 
the contrary, in Algarve, each one of the two hospitals are responsible for approximately 
50% of the stroke episodes in the region.  
In terms of age distribution, there is a clear dominance of episodes in patients with 
ages between 60 and 90 years old. Give the eligibility criteria of the program, approximately 
65% of all the ischemic stroke patients are potential beneficiaries of Via Verde.  
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Graph 5 – Sample distribution by Hospital and ARS (%)      Graph 6 – Sample distribution by Age (cum %) 
 
When gender is considered, the incidence of stroke is similarly distributed among men 
and women, and this trend has been maintained through time. In what concerns the overall 
health state of stroke patients, the large majority presents 3 diagnosis other than stroke, and 
almost 80% have 5 or less secondary diagnosis. 
 
         
 Graph 7 - Distribution by Gender/ Year (%) Graph 8 - Distribution by Number of Diagnosis (%) 
 
             
1.3. Mortality Trends of Ischemic Stroke Patients 
Although there is no clear trend on mortality for ischemic stroke patients with less 
than 40 years (mainly explained by the small number of observations), there is an observable 
positive relation between average mortality and age, as patients get older.  
Moreover, the total mortality by stroke has decreased since 2004 from 16% to 13% of 
stroke episodes; however, this trend is not so clear for ischemic stroke patients, nor for the 
program’s target patients, for whom mortality has remained around 11%-13%, and 8%, 
respectively. So, the decrease in the total mortality can only be explained by a sharp 
decrease in mortality of hemorrhagic stroke patients to percentages similar to those 
observed in ischemic stroke patients.   
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 Graph 9 - Average mortality rate (%) by age Graph 10 - Average mortality (%) by year 
 
When comparing mortality by gender for all ages, data shows a higher fraction of 
women dying from stroke; moreover, when age is controlled, this difference remains, 
although the mortality rates are lower, at around 7,5% and 9% for men and women, 
respectively.  
Additionally, there is an upward relationship between the stroke patients’ health 
status (measured by the number of diagnosis) and mortality by stroke, especially in the case 
that only the target patients are considered. 
          
 Graph 11 - Average mortality rate (%) by gender Graph 12 - Average Mortality by Health Status (%) 
 
A summary of the descriptive statistics of the data used are presented on Appendix 3. 
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2. Regression Analysis   
2.1. In-hospital Mortality 
Table 3 – The Overall Impact of Via Verde do AVC: results of In-hospital analysis  
 
THE OVERALL IMPACT OF VIA VERDE DO AVC 
SCOPE OF ANALYSIS VARIABLE COEFFICIENT P> |Z| 
95% CONF 
INTERVAL 
SIGNIF. N. OBS. PSEUDO R
2
 REGRESSION 
Ischemic stroke 
VV 0,100 0,206 [-0,05; 0,25] ✘ 
28.837 4,14% 
xi: logit DMort VV Nddx sex age age2 age3 i.year  
i.hosp_id if (age>18 & age<80 & isch==1) 
Nddx 0,091 0,000 [0,08; 0,11] ✔ 
Ischemic stroke, ARS Norte VV 0,091 0,273 [-0,07; 0,25] ✘ 26.941 4,17% 
xi: logit DMort VV Nddx sex age age2 age3 i.year  
i.hosp_id if (age>18 & age<80 & isch==1 & ars==1) 
Ischemic stroke, limited 
number of diagnosis (1) 
VV 0,391 0,337 [-0,41; 1,91] ✘ 1.323 12,16% 
xi: logit DMort VV Nddx sex age age2 age3 i.year  
i.hosp_id if (age>18 & age<80 & isch==1 & Nddx==1) 
Hemorrhagic stroke VV -0,076 0,493 [-0,29; 0,14] ✘ 5.798 2,27% 
xi: logit DMort VV Nddx sex age age2 age3 i.year  
i.hosp_id if (age>18 & age<80 & isch==0) 
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Table 4 – The Breakdown Impact of Via Verde do AVC: results of In-hospital analysis  
THE BREAKDOWN IMPACT OF VIA VERDE DO AVC 
SCOPE OF 
ANALYSIS 
VV 
VARIABLE 
COEFFICIENT P> |Z| 
95% CONF 
INTERVAL 
SIGNIF. N. OBS. PSEUDO R
2
 REGRESSION 
Breakdown by 
Expertise 
VV1 0,109 0,204 [-0,06; 0,28] ✘ 
28.837 4,14% 
xi: logit DMort VV1 VV2 VV3 VV4 VV5 Nddx sex age age2 
i.year i.hosp_id if (age>18 & age<80 & isch==1) 
VV2 0,097 0,346 [-0,11; 0,30] ✘ 
VV3 -0,002 0,985 [-0,26; 0,25] ✘ 
VV4 -0,017 0,922 [-0,36; 0,33] ✘ 
VV5 0,176 0,624 [-0,53; 0,88] ✘ 
Breakdown by 
Year 
VV05 O,575 0,097 [-0,10; 1,25] ✘ 
28.837 4,16% 
xi: logit DMort  VV05 VV06 VV07 VV08 VV09 Nddx sex age 
age2 i.year i.hosp_id if (age>18 & age<80 & isch==1) 
VV06 0,014 0,928 [-0,28; 0,31] ✘ 
VV07 0,202 0,101 [-0,04; 0,44] ✘ 
VV08 0,128 0,306 [-0,12; 0,37] ✘ 
VV09 -0,025 0,842 [-0,28; 0,23] ✘ 
Breakdown by 
Expertise and 
Year 
VV05_1 0,559 0,112 [-0,13; 1,25] ✘ 
28.837 4,19% 
xi: logit DMort VV05_1 VV06_1 VV06_2 VV07_1  VV07_2 
VV07_3 VV08_1 VV08_2 VV08_3 VV08_4 VV09_1 VV09_2 
VV09_3 VV09_4 VV09_5 Nddx sex age age2 i.year i.hosp_id if 
(age>18 & age<80 & isch==1) 
VV06_1 -0,018 0,920 [-0,36; 0,33] ✘ 
VV06_2 0,075 0,824 [-0,59; 0,74] ✘ 
VV07_1 0,184 0,271 [-0,14; 0,51] ✘ 
VV07_2 0,184 0,284 [-0,15; 0,52] ✘ 
VV07_3 0,119 0,762 [-0,65; 0,88] ✘ 
VV08_1 0,018 0,920 [-0,33; 0,36] ✘ 
VV08_2 0,137 0,440 [-0,21; 0,48] ✘ 
VV08_3 0,076 0,688 [-0,29; 0,45] ✘ 
VV08_4 0,498 0,138 [-0,16; 1,16] ✘ 
VV09_1 0,128 0,427 [-0,19; 0,44] ✘ 
VV09_2 -0,072 0,686 [-0,42; 0,28] ✘ 
VV09_3 -0,134 0,454 [-0,49; 0,22] ✘ 
VV09_4 -0,145 0,466 [-0,54; 0,25] ✘ 
VV09_5 0,123 0,736 [-0,59; 0,84] ✘ 
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The tables above summarize the results of in-hospital analysis. 
When considering the impact of the program on the target group (ischemic stroke 
patients with age above 18 and below 80 years old), measured by a single VV variable, there 
is no statistical evidence of impact of Via Verde do AVC on mortality (p-value=21%>5%). 
Moreover, sex, age, age2 and age3 are not significant; however, once age3 is excluded from 
the regression, age2 become a positively significant variable. In what concerns time-effects, 
2008 is the only year that shows significant improvements when compared to 2004, but if 
the variables are jointly tested, they are not statistically different from zero (P> χ2 = 30,4%). 
On the other hand, the differences among the various hospitals are captured in the 
regression, and their coefficients show jointly statistical difference from zero (P> χ2 = 0,00%). 
Moreover, the impact of the number of diagnosis on mortality is also highly significant. The 
explanatory power of this analysis (R2) is around 4%. 
Furthermore, in none of the cases analyzed with a single VV variable, has the 
outcomes shown statistical significance: not for other stroke types (Hemorrhagic stroke 
episodes), not for a specific region (ARS Norte episodes), nor for episodes with restricted 
health status (limited number of diagnosis).  
So, based on this analysis, it is not possible to conclude that the program was able to 
improve the health status of stroke patients, through the decrease of in-hospital mortality. 
 
Based on the second approach, using the breakdown effect of the program, the results 
obtained show similar conclusions. When only the degree of expertise is controlled (VV1-
VV5), there is no evidence of statistically significant impact on ischemic stroke mortality, and 
so it is not clear whether the program can actually improve health status of these patients as 
a result of the increased experience of the team involved. Furthermore, when the impact of 
‘Via Verde do AVC’ is only controlled by the year in which the observation occurred, the 
results achieved are not better, as shown in the table above. Also, in the case that the effect 
of the program is broken-down according to both year of the episode, and the degree of 
expertise of the hospital, there is no statistically significant decrease in mortality of ischemic 
stroke patients captured in any the VV variables. In all of these analyses, the number of 
diagnosis is highly significant, as well as age2 (once age3 is removed), or age (once age2 is 
removed). In all of these approaches, differences among hospitals are jointly significantly 
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different from zero (P > χ2 = 0,00%), while there is no jointly statistical evidence that time 
has contributed for a shift on stroke mortality (P > χ2 = 44%, 40% and 46%, respectively).   
So, there is no evidence that the program can reduce ischemic stroke mortality in-
hospital, even if the impact is broken down by degree of expertise and/or year of 
observation. Details on the in-hospital regression are presented on Appendix 4. 
Nevertheless, it is interesting to notice that, in cases that Via Verde exists, a greater 
proportion of patients with worse health status (measured by number of diagnoses) arrives 
at the hospital, than in the cases without the program.  
 
N. of Diagnosis Distribution (%), by existence of VV 
 
Graph 13 – Health Status distribution (%): all observations  Graph 14 – Health Status distribution (%): S. João Hospital 
This fact could be a result of the type of hospitals that have the program, rather than 
the program itself - since it is generally implemented in central hospitals that, a priori, 
receive more complex cases than those without it. However, this pattern holds even if we 
consider Hospital S. João – the largest in the region: although, without Via Verde, it receives 
a higher percentage of complex cases than the average hospitals, this percentage is even 
higher since Via Verde was implemented.   
Based on this finding, it is possible to speculate on the impact of the program not in 
terms of decreased in-hospital mortality, but instead on change in the overall probability of 
mortality – so that the greatest value-added of the program would be in the ability of the 
patients to arrive to the hospital before they are dead. In this sense, once the patient arrives 
to the hospital alive, there is no great impact on having the program. Nevertheless, having 
the program allows that a greater percentage of patients arrive to the hospital alive, where 
their probability of survival is higher than if they were somewhere else. These effects should 
then be tested based on regional/population level  (rather than in-hospital) data. 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
25 | P a g e  
 
2.2. Regional Mortality 
Table 5 – Simple Linear Regression: results of Regional analysis 
 
 Table 6 - Population-Weighted Linear Regression: results of Regional analysis  
 
According to the results obtained in both approaches (simple, and population-
weighted) of the regional analysis, there is, once again, no statistical evidence that the 
existence of ‘Via Verde do AVC’ in the regions translate into better health results for stroke 
patients (p-value=30% and 10%, respectively). 
On the other hand, there are large differences among regions and throughout the 
years, since the joint tests show that the respective coeficients are stastically different from 
zero (P > F =0,00%). It is also relevant to notice that mortality by stroke has been decreasing 
sharply since 2002: taking 2001 as reference, the coefficients of the years’ variables present 
negative values, ranging from -14,0/100.000 in 2002, to -60,7/100.000 in 2009), which mean 
SIMPLE LINEAR REGRESSION 
xi: reg smr i.region_code i.year VV N. Observ: 216 
Adj R
2 
= 86,8% F (32, 183) = 45,14 Prob > F = 0,000 
 
VARIABLE COEFF P> |t| 95% CONF INT. SIGNIF. 
VV 2,7 0,3 [-2,6; 8,0] ✘ 
 
JOINT TEST 
Variables F Prob > F Signif. 
region F (23, 183) = 26,33 0,000 ✔ 
year F (8, 183) = 75,27  0,000 ✔ 
POPULATION-WEIGHTED LINEAR REGRESSION 
xi: reg smr i.region_code i.year VV [w=pop] N. Observ: 216 
Adj R
2 
= 87,7% F (32, 183) = 48,96 Prob > F = 0,000 
 
VARIABLE COEFF P> |t| 95% CONF INT. SIGNIF. 
VV 4,1 0,1 [-1,1; 9,2] ✘ 
 
JOINT TEST 
Variables F Prob > F Signif. 
region F (23, 183) = 29,14 0,000 ✔ 
year F (8, 183) = 80,02 0,000 ✔ 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
26 | P a g e  
 
that mortality has been decreasing over time, far before the beginning of ‘Via Verde do AVC’. 
Moreover, the explanatory power of both regression are very high (R2 of around 87%). 
Detailed information on the results of regional analysis are presented on Appendix 5. 
In what concerns the program’s impact on mortality, and answering the hypothesis 
raised in the previous section, these results do not confirm it. There is no evidence that 
overal stroke mortality decreased due to ‘Via Verde do AVC’. Since the previous results had 
shown that in-hospital mortality did no change, any changes in global mortality would have 
to come from periods not "in hospital". One possibility was that thanks to ‘Via Verde do 
AVC’, pre-hospital survival would have improved. However,these last results show that such 
explanation is not valid. There is little reason to believe that the program decreases 
mortality before or during a hospital stroke episode.  
 
3. Program’s Limitations that might explain the Results obtained 
Given the fact that none of the analysis performed showed significant effectiveness of 
the program ‘Via Verde do AVC’, it is not relevant to further analyse the costs involved in the 
program, and the consequent cost-effectiveness relationship. 
Nevertheless, it would be interestig to focus on the program’s design and 
implementation strategy, in order to better understand the possible causes that are limiting 
its success. 
 
3.1. Promotion and Reach 
The trigger of the whole process is the people’s intervention, by calling the emergency 
services and being able to identify the ocurrence of a stroke episode. In this sense, 
promotion and informative campaigns to increase the population’s awareness is critical for 
the success of the program. However, in Portugal, the program has not been heavily 
promoted and many people are still not aware of its existence.   
 Indeed, when considering the North region (the one with the largest adherence rates), 
and through time, as more hospitals implement the program, the population covered in 
regional terms, as well as the percentage of patients that arrive at hospitals with Via Verde 
increases dramatically (from around 20% to 70%). However, the percentage of patients that 
are actually using it – although increasing at a similar rate –, is only about half of the 
potential number of episodes that could have used the program.  
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Program’s Potential vs. Actual Reach 
 
Graph 15 – (INE; ARSN, 2011), (GDH, 2004-2009), (ACS; CNDCV, 2010) 
 
Based on this figures, it is possible to argue that it is not enough to create more 
infrastructures to tackle the problem: it is also critical to involve the population on this 
program, to make them aware of its existence and thus, to translate potential impact on 
actual impact. Indeed, the current potential capacity of the program is twice as much as the 
number of patients currently served by it.    
 
3.2. Training and Expertise 
In order to achieve the best outcomes possible, it is important that everybody involved 
in the process is fully capable and knowlegeable about it. In this sense, training should be 
continuously implemented – and, indeed, this issue is constantly mentioned in the 
document that stablishes the guidelines of the program (“Documento Orientador das Vias 
Verdes de EAM e de AVC”).  
The ability to readily identify the syptoms, along with a quick response from 
emergency and medical teams, in order to initiate the trombolitic treatment in due time, are 
of major importance.  
When considering data on the time elapsed since the beginning of syptoms until arrival 
to the hospital (“onset-to-door”), not much improvement has been achieved since the 
implementation of the program, and approximately 50% of the patients transported by 
INEM take longer than 1hour to arrive to the hospital (however, since INEM only publishes 
data since 2007, it is not possible to assess the differences between the period before and 
after the program’s implementation).  
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Along with this, goes the fact that, of all the episodes that meet the program’s 
requirements (ischemic stroke patients with age between 18 and 80), only a small fraction 
has been treated with rt-PA (from 1% in 2005 to 7% in 2008), which means that the ultimate 
purpose of the program (providing the stroke patients with trombolitic treatment) is very 
rarely achieved and only a very small fraction of the target population is actually beneficting 
from the process in full. 
 
“Onset-to-door” time – 2007-2009  Target Episodes vs. Number of Trombolysis  
   
       
Graph 16 – (INEM)  Graph 17 – (GDH, 2004-2009), (ARSN, 2009) 
 
 
3.3. Post-hospital Care and Rehabilitation 
Another very relevant stage of the stroke process is post-hospital care. As mentioned 
before, many countries have adopted programs that include rehabilitation treatment, in 
order to improve the patients health conditions and their functional status, since many of 
those who survive are still limited in their phisical conditions. 
In Portugal, in particular, although there is the intention to include this stage in the 
process, there is not much information concerning its actual implementation and 
monitoring. Also, there is no systematic track of the patients’ health status after hospital 
discharge, and thus, no information on their evolution over time. 
For this reason, and now that the pre and intra-hospital stages are already 
implemented, it would be important to focus on this issue and to develop mechanisms that 
would allow stroke patiens to have comprehensive access to post-hospital health care 
services – properly designed, implemented, and monitored –, thus maximizing the program’s 
reach throughout the whole process of stroke treatment. 
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VI. CONCLUSIONS 
 
 The worldwide burden of mortality by stroke has created the need to develop actions 
focused on this issue and, in line with what has been done in many countries, Portugal 
created the program ‘Via Verde do AVC’, aimed to ultimately reduce stroke mortality in the 
country. 
Since the program’s implementation in 2005 until nowadays, data has shown a sharp 
and steady decrease on stroke mortality in Portugal. However, according to the analysis 
performed in this thesis, considering both in-hospital observations, as well as population 
level data, there is no statistical evidence that such decrease is related to the 
implementation of ‘Via Verde do AVC’. 
Moreover, once only the program’s target population (ischemic stroke patients aged 
between 18 and 80 years old) is considered, the declining trend on mortality is not so clear. 
Indeed, the overall trend observed seems to be mainly due to the decrease of mortality 
rates in hemorrhagic stroke patients.  
Besides that, it is also worth mentioning that stroke mortality shows declining rates 
since 2001 - far before the implementation of "Via Verde do AVC". 
 
In an attempt to understand the reason for this results, some possible explanations 
were presented. First of all, the efforts on Promotion and Information campaigns about the 
program might have not been enough to reach as many people as it would be possible and 
desireable. Second, despite the large investments on infrastructures and equipment to allow 
a faster and better transport and treatment of patients, there is still a very small fraction of 
the target population being treated with rt-PA medicin as they should . Finally, the poor 
implementation of post-hospital care might further limit the results of the overall program, 
given the fact that at this stage is very important to give the patients access to rehabilitation 
services and thus improving their overall health status. 
The analysis itself also has some limitations. As it focus on a limited number of 
regions, it is not possible to reach conclusions for the whole country. Moreover, in the case 
of regional analysis, the data was too aggregated, so that it was not possible to clearly define 
the implementation date of the program in each region (since the data was on a yearly-
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basis), nor to exclude observations that did not meet the program’s requirements (there was 
only one stroke category, and age groups were different from those established by the 
program). Nevertheless, it is important to mention that the North region – the main focus of 
the analysis – is, indeed, the region with the longest period of implementation, the greatest 
adherence rates, and with the lowest degree of patient flows across regions; so, if one single 
region should be chosen, this is, apparently, the best one to choose. 
Given these limitations, it would be interesting to further explore the topic in future 
research, including more regions, as well as more accurate data on regional analysis. 
In a more technical perspective, and given the fact that stroke is a health problem 
that, besides death, also tends to cause significant disability on those who survive, it is 
equally relevant to evaluate the impact of the program not only based on mortality, but also 
assessing the improvement on functional status of stroke patients since the implementation 
of ‘Via Verde do AVC’, both at hospital discharge and after rehabilitation. 
 
In short, although the results obtained do not show a very positive picture, it brings to 
light some important insights of what can be done differently. In this sense, this work should 
be interpreted as a driving force to continuously strive for the development of better and 
more effective mechanisms, in which resources are properly alocated and used – afterwards, 
“Improvement” is a  never-ending process. 
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APPENDICES 
 
 
Appendix 1: Hospitals – hosp_id Match and Starting Date of “Via Verde do AVC”  
 
hosp_id 
2009 
hosp_id 
Hospital Starting date VV1 
AMAR - H. S. Gonçalo - 
ANTO P010 H Geral S António 15-11-2005 
BARC P013 H. Sta. Maria Maior - 
BRAC P017 U. H. Bragança 19-01-2009 
BRAG P018 H S. Marcos 05-02-2007 
CHAV P027 U. H. Chaves - 
FAFE - U.H. Fafe - 
FAMA P068 U. H. Famalicão - 
FEIR P071 H S. Sebastião 15-11-2005 
GAIA P074 H Eduardo Santos Silva 03-03-2008 
GUIM P079 U. H. Guimarães 01-04-2009 
IPOP P093 IPO Porto - 
JOAO P094 H. S. João 15-11-2005 
LAME - U.H. Lamego - 
MACE P101 U. H. Macedo de Cavaleiros - 
MATO P107 H. Pedro Hispano 01-09-2008 
MIRA P108 U. H. Mirandela - 
OLIV P112 H. São Miguel - 
REAL P128 H. S. Pedro deVila Real 03-03-2007 
TIRS - U.H. Sto Tirso - 
VALE P141 H. Pe. Américo, V. Sousa 22-06-2009 
VALO P142 H. N. Sra. Da Conceição do Valongo - 
VARZ P143 U.H. Póvoa Varzim - 
VIAN P145 H. Sta Luzia de Viana do Castelo 01-09-2009 
FARO P070 H. Faro 01-08-2007 
PMAO P121 H. Portimão 01-08-2007 
  
                                                          
1
 Source: (ARSN, 2009); (ARSA, 2010) 
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Appendix 2: Hospital – “Concelhos” – Region Match (only Hospitals with VV) 
 
hosp_id Concelhos2 Region3 
ANTO Porto - Gondomar Porto; Gondomar 
BRAC 
Bragança - Miranda do Douro - Mogadouro - Vimioso - 
Vinhais 
Nordeste 
BRAG 
Amares - Braga - Póvoa de Lanhoso - Terras de Bouro - Vieira 
do Minho - Vila Verde 
Gerês/ Cabreira; Braga 
FEIR 
Arouca - Santa Maria da Feira - Oliveira de Azeméis - Ovar - 
São João da Madeira - Vale de Cambra 
Feira/ Arouca; Aveiro 
Norte 
GAIA Espinho (Aveiro) - Vila Nova de Gaia(Porto) Gaia/ Espinho 
GUIM 
Cabeceiras de Basto - Celorico de Basto - Fafe - Guimarães - 
Vizela 
Guimarães/ Vizela; Terras 
de Basto 
JOAO Porto – Maia – Valongo  Porto; Maia; Valongo 
MATO Matosinhos Matosinhos 
REAL 
Alijó - Mesão Frio - Mondim de Basto - Murça - Peso da Régua 
- Ribeira de Pena - Sabrosa - Santa Marta de Penaguião - Vila 
Pouca de Aguiar - Vila Real 
Marão e Douro Norte 
VALE 
Amarante - Baião - Felgueiras - Paços de Ferreira - Paredes - 
Penafiel 
Vale Sousa Norte; Vale 
Sousa Sul; Baixo Tâmega 
VIAN 
Caminha - Melgaço - Monção - Valença - Viana do Castelo - 
Vila Nova de Cerveira 
Alto Minho 
 
 
 
  
                                                          
2
 (Portal da Saúde > Prestadores) 
3
 (ARSN, 2008), (mort@lidades) 
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Appendix 3: Descriptive Statistics of In-hospital data (GDH 2004-2009) 
 
 
  
STATS 
 
VAR 
MEAN STD. DEV RANGE N. OBSERV 
Total 
Program 
Criteria 
Total 
Program 
Criteria 
Total 
Program 
Criteria 
Total 
Program 
Criteria 
DMort 14,6% 8,1% 35,3% 27,3% [0 = Alive; 1 = Dead] 
51.603 28.842 
sex 49,8% 43,6% 50,0% 49,6% [0 = Man; 1 = Woman] 
age 72,6 67,3 12,6 10,3 [0-113] [19-79] 
Nddx 5,25 5,26 3,50 3,46 [1-20] 
VV 29,1% 30,9% 45,4% 46,2% [0 = No VV; 1 = Yes VV] 
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Appendix 4: In-hospital Analysis - detailed results 
  
1. Ischemic stroke 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV 0,100 0,079 1,26 0,21 -0,05 0,25 
Nddx 0,091 0,008 11,46 0,00 0,08 0,11 
sex 0,078 0,044 1,76 0,08 -0,01 0,16 
age 0,115 0,147 0,78 0,43 -0,17 0,40 
age2 -0,193 0,248 -0,78 0,44 -0,68 0,29 
age3 0,139 0,138 1,01 0,31 -0,13 0,41 
_Iyear_2005 -0,053 0,077 -0,7 0,49 -0,20 0,10 
_Iyear_2006 -0,054 0,077 -0,7 0,48 -0,20 0,10 
_Iyear_2007 -0,050 0,080 -0,63 0,53 -0,21 0,11 
_Iyear_2008 -0,200 0,087 -2,29 0,02 -0,37 -0,03 
_Iyear_2009 -0,106 0,093 -1,14 0,26 -0,29 0,08 
_Ihosp_id_2 -0,314 0,180 -1,74 0,08 -0,67 0,04 
_Ihosp_id_3 -0,168 0,191 -0,88 0,38 -0,54 0,21 
_Ihosp_id_4 0,333 0,210 1,59 0,11 -0,08 0,74 
_Ihosp_id_5 0,012 0,165 0,07 0,94 -0,31 0,33 
_Ihosp_id_6 -0,106 0,190 -0,56 0,58 -0,48 0,27 
_Ihosp_id_8 0,141 0,199 0,71 0,48 -0,25 0,53 
_Ihosp_id_9 -0,604 0,210 -2,88 0,00 -1,02 -0,19 
_Ihosp_id_10 0,027 0,188 0,15 0,89 -0,34 0,40 
_Ihosp_id_11 -0,311 0,186 -1,67 0,10 -0,68 0,05 
_Ihosp_id_12 -0,162 0,166 -0,97 0,33 -0,49 0,16 
_Ihosp_id_13 -0,410 0,165 -2,48 0,01 -0,73 -0,09 
_Ihosp_id_14 0,453 0,508 0,89 0,37 -0,54 1,45 
_Ihosp_id_15 -1,035 0,174 -5,94 0,00 -1,38 -0,69 
_Ihosp_id_16 0,020 0,211 0,09 0,93 -0,39 0,43 
_Ihosp_id_17 0,280 0,197 1,42 0,16 -0,11 0,67 
_Ihosp_id_18 0,341 0,166 2,06 0,04 0,02 0,67 
_Ihosp_id_19 0,856 0,188 4,57 0,00 0,49 1,22 
_Ihosp_id_20 -0,337 0,226 -1,49 0,14 -0,78 0,11 
_Ihosp_id_21 0,244 0,177 1,38 0,17 -0,10 0,59 
_Ihosp_id_22 0,229 0,165 1,39 0,16 -0,09 0,55 
_Ihosp_id_23 -0,411 0,243 -1,69 0,09 -0,89 0,07 
_Ihosp_id_24 -0,255 0,165 -1,55 0,12 -0,58 0,07 
_Ihosp_id_25 -0,561 0,267 -2,1 0,04 -1,08 -0,04 
_Ihosp_id_26 0,064 0,194 0,33 0,74 -0,32 0,44 
_Ihosp_id_27 -0,190 0,161 -1,18 0,24 -0,51 0,13 
_cons -6,091 2,826 -2,16 0,03 -11,63 -0,55 
Stats 
Number of obs = 28837 
LR  χ
2
 (36) = 673.53 
Prob >  χ
2
 = 0.0000 
Pseudo R2 = 0,0414 
Joint Tests 
year χ
2
 (5) = 6.02 
Prob > χ
2
 = 0.3040 
hospital χ
2
 (25) =  257.27 
Prob > χ
2
 = 0.0000 
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Stats 
Number of obs = 26941 
LR  χ
2 
(34) = 627,85 
Prob >  χ
2
 = 0,0000 
Pseudo R2 = 0,0417 
Joint Tests 
year χ
2
 (5) = 5.64 
Prob > χ
2
 = 0.3040 
hospital χ
2
 (25) =  242.68 
Prob > χ
2
 = 0.0000 
2. ARS Norte 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV 0,091 0,083 1,100 0,273 -0,072 0,255 
Nddx 0,090 0,008 11,050 0,000 0,074 0,106 
sex 0,067 0,046 1,460 0,143 -0,023 0,158 
age 0,181 0,155 1,160 0,244 -0,123 0,485 
age2 -0,314 0,263 -1,200 0,231 -0,829 0,200 
age3 0,210 0,145 1,440 0,149 -0,075 0,494 
_Iyear_2005 -0,050 0,078 -0,640 0,522 -0,202 0,103 
_Iyear_2006 -0,041 0,079 -0,520 0,603 -0,195 0,113 
_Iyear_2007 -0,060 0,082 -0,730 0,464 -0,222 0,101 
_Iyear_2008 -0,198 0,089 -2,220 0,026 -0,372 -0,024 
_Iyear_2009 -0,104 0,096 -1,080 0,280 -0,292 0,085 
_Ihosp_id_2 -0,305 0,181 -1,680 0,092 -0,659 0,050 
_Ihosp_id_3 -0,164 0,191 -0,860 0,391 -0,539 0,211 
_Ihosp_id_4 0,332 0,210 1,580 0,113 -0,079 0,743 
_Ihosp_id_5 0,016 0,165 0,100 0,924 -0,308 0,339 
_Ihosp_id_6 -0,106 0,190 -0,560 0,578 -0,478 0,266 
_Ihosp_id_8 0,139 0,199 0,700 0,485 -0,251 0,530 
_Ihosp_id_9 -0,605 0,210 -2,880 0,004 -1,017 -0,193 
_Ihosp_id_11 -0,305 0,187 -1,630 0,103 -0,672 0,062 
_Ihosp_id_12 -0,159 0,167 -0,950 0,342 -0,485 0,168 
_Ihosp_id_13 -0,410 0,165 -2,480 0,013 -0,733 -0,086 
_Ihosp_id_14 0,460 0,508 0,910 0,365 -0,535 1,456 
_Ihosp_id_15 -1,018 0,176 -5,800 0,000 -1,362 -0,674 
_Ihosp_id_16 0,019 0,211 0,090 0,928 -0,394 0,432 
_Ihosp_id_17 0,280 0,197 1,420 0,156 -0,107 0,667 
_Ihosp_id_18 0,342 0,166 2,060 0,039 0,017 0,667 
_Ihosp_id_19 0,853 0,188 4,550 0,000 0,486 1,221 
_Ihosp_id_20 -0,331 0,226 -1,460 0,143 -0,774 0,112 
_Ihosp_id_22 0,233 0,165 1,410 0,158 -0,091 0,557 
_Ihosp_id_23 -0,411 0,243 -1,690 0,091 -0,887 0,065 
_Ihosp_id_24 -0,253 0,165 -1,540 0,124 -0,577 0,070 
_Ihosp_id_25 -0,557 0,267 -2,090 0,037 -1,079 -0,034 
_Ihosp_id_26 0,065 0,194 0,330 0,739 -0,316 0,446 
_Ihosp_id_27 -0,190 0,161 -1,180 0,238 -0,507 0,126 
_cons -7,200 3,002 -2,400 0,016 -13,084 -1,316 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
36 | P a g e  
 
 
 
Stats 
Number of obs = 1323 
LR χ
2
 (30) = 86,76 
Prob > χ
2
 = 0,0000 
Pseudo R2 = 0,1216 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3. Limited Diagnosis 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV 0,391 0,408 0,960 0,337 -0,408 1,191 
sex 0,392 0,222 1,760 0,078 -0,044 0,828 
age -0,157 0,515 -0,300 0,761 -1,166 0,852 
age2 0,381 0,915 0,420 0,677 -1,412 2,175 
age3 -0,215 0,526 -0,410 0,683 -1,246 0,816 
_Iyear_2005 -0,696 0,372 -1,870 0,062 -1,426 0,034 
_Iyear_2006 -1,187 0,443 -2,680 0,007 -2,055 -0,319 
_Iyear_2007 0,008 0,349 0,020 0,981 -0,676 0,693 
_Iyear_2008 -0,736 0,415 -1,770 0,076 -1,549 0,077 
_Iyear_2009 -0,575 0,446 -1,290 0,197 -1,448 0,299 
_Ihosp_id_2 2,517 0,907 2,770 0,006 0,738 4,296 
_Ihosp_id_4 1,287 0,967 1,330 0,183 -0,609 3,183 
_Ihosp_id_5 1,353 0,872 1,550 0,121 -0,356 3,062 
_Ihosp_id_6 1,817 0,982 1,850 0,064 -0,108 3,742 
_Ihosp_id_8 1,371 0,816 1,680 0,093 -0,228 2,970 
_Ihosp_id_9 0,577 1,039 0,560 0,578 -1,459 2,614 
_Ihosp_id_10 -0,039 1,043 -0,040 0,970 -2,084 2,005 
_Ihosp_id_11 1,285 0,895 1,440 0,151 -0,468 3,039 
_Ihosp_id_12 0,028 0,943 0,030 0,977 -1,821 1,877 
_Ihosp_id_13 0,752 0,835 0,900 0,368 -0,884 2,387 
_Ihosp_id_16 0,242 1,260 0,190 0,848 -2,228 2,712 
_Ihosp_id_17 0,764 1,042 0,730 0,463 -1,278 2,806 
_Ihosp_id_18 2,152 0,905 2,380 0,017 0,378 3,926 
_Ihosp_id_19 1,638 0,881 1,860 0,063 -0,088 3,364 
_Ihosp_id_21 0,740 0,816 0,910 0,364 -0,859 2,339 
_Ihosp_id_22 0,661 0,841 0,790 0,432 -0,988 2,310 
_Ihosp_id_23 2,077 1,102 1,880 0,060 -0,084 4,238 
_Ihosp_id_24 0,093 1,037 0,090 0,929 -1,940 2,125 
_Ihosp_id_26 1,807 0,885 2,040 0,041 0,073 3,541 
_Ihosp_id_27 1,037 0,804 1,290 0,197 -0,539 2,613 
_cons -3,463 9,370 -0,370 0,712 -2,183 1,490 
Joint Tests 
year χ
2
 (5) = 6.02 
Prob > χ
2
 = 0.3040 
hospital χ
2
 (25) =  257.27 
Prob > χ
2
 = 0.0000 
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Stats 
Number of obs = 5798 
LR  χ
2
(36) = 160,37 
Prob >  χ
2
 = 0,0000 
Pseudo R2 = 0,0227 
Joint Tests 
year χ
2
 (5) = 19.05 
Prob > χ2 = 0.0019 
hospital χ
2
 (25) =  85.02 
Prob > χ
2
 = 0.0000 
4. Hemorrhagic Stroke 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV -0,076 0,111 -0,690 0,493 -0,292 0,141 
Nddx -0,004 0,009 -0,400 0,692 -0,022 0,015 
sex -0,073 0,060 -1,220 0,224 -0,190 0,044 
age 0,234 0,094 2,500 0,013 0,050 0,419 
age2 -0,460 0,174 -2,640 0,008 -0,802 -0,118 
age3 0,297 0,105 2,840 0,004 0,092 0,502 
_Iyear_2005 -0,055 0,083 -0,660 0,512 -0,218 0,108 
_Iyear_2006 -0,121 0,090 -1,350 0,177 -0,297 0,055 
_Iyear_2007 -0,098 0,098 -0,990 0,320 -0,290 0,095 
_Iyear_2008 -0,780 0,284 -2,740 0,006 -1,338 -0,223 
_Iyear_2009 -10,553 0,286 -3,690 0,000 -16,164 -0,494 
_Ihosp_ida2 0,519 0,266 1,950 0,051 -0,002 1,040 
_Ihosp_ida3 0,152 0,328 0,460 0,644 -0,491 0,795 
_Ihosp_ida4 0,530 0,337 1,570 0,116 -0,130 1,191 
_Ihosp_ida5 0,171 0,263 0,650 0,516 -0,344 0,686 
_Ihosp_ida6 0,566 0,296 1,910 0,056 -0,014 1,146 
_Ihosp_ida8 0,172 0,367 0,470 0,638 -0,546 0,891 
_Ihosp_ida9 0,441 0,329 1,340 0,180 -0,204 1,086 
_Ihosp_ida10 0,683 0,266 2,570 0,010 0,162 1,205 
_Ihosp_ida11 -0,279 0,315 -0,890 0,376 -0,896 0,338 
_Ihosp_ida12 0,576 0,274 2,100 0,035 0,039 1,112 
_Ihosp_ida13 0,446 0,276 1,620 0,106 -0,094 0,987 
_Ihosp_ida14 1,272 0,604 2,100 0,035 0,087 2,456 
_Ihosp_ida15 0,788 0,268 2,940 0,003 0,262 1,313 
_Ihosp_ida16 0,317 0,377 0,840 0,401 -0,423 1,057 
_Ihosp_ida17 0,670 0,344 1,950 0,051 -0,003 1,343 
_Ihosp_ida18 0,860 0,270 3,190 0,001 0,331 1,389 
_Ihosp_ida19 0,398 0,353 1,130 0,259 -0,294 1,089 
_Ihosp_ida20 0,487 0,373 1,310 0,192 -0,244 1,218 
_Ihosp_ida21 0,722 0,286 2,520 0,012 0,161 1,282 
_Ihosp_ida22 0,265 0,288 0,920 0,358 -0,300 0,829 
_Ihosp_ida23 -0,381 0,512 -0,740 0,456 -1,384 0,622 
_Ihosp_ida24 0,340 0,281 1,210 0,226 -0,210 0,890 
_Ihosp_ida25 -1,323 1,068 -1,240 0,215 -3,415 0,769 
_Ihosp_ida26 0,302 0,336 0,900 0,369 -0,357 0,961 
_Ihosp_ida27 0,103 0,277 0,370 0,711 -0,440 0,645 
_cons -5,224 1,648 -3,170 0,002 -8,453 -1,995 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
38 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
  
5. Breakdown: Expertise 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV1 0,109 0,086 1,270 0,204 -0,059 0,277 
VV2 0,097 0,103 0,940 0,346 -0,105 0,300 
VV3 -0,002 0,129 -0,020 0,985 -0,255 0,250 
VV4 -0,017 0,177 -0,100 0,922 -0,364 0,330 
VV5 0,176 0,358 0,490 0,624 -0,525 0,876 
Nddx 0,092 0,008 11,500 0,000 0,076 0,108 
sex 0,078 0,044 1,750 0,079 -0,009 0,164 
age -0,029 0,026 -1,130 0,259 -0,079 0,021 
age2 0,056 0,020 2,790 0,005 0,016 0,095 
_Iyear_2005 -0,053 0,077 -0,700 0,486 -0,204 0,097 
_Iyear_2006 -0,056 0,077 -0,720 0,470 -0,206 0,095 
_Iyear_2007 -0,050 0,080 -0,620 0,532 -0,207 0,107 
_Iyear_2008 -0,180 0,089 -2,030 0,043 -0,355 -0,006 
_Iyear_2009 -0,071 0,101 -0,700 0,484 -0,268 0,127 
_Ihosp_id_2 -0,297 0,181 -1,640 0,102 -0,652 0,059 
_Ihosp_id_3 -0,178 0,191 -0,930 0,353 -0,553 0,197 
_Ihosp_id_4 0,327 0,210 1,560 0,119 -0,084 0,739 
_Ihosp_id_5 0,017 0,165 0,100 0,917 -0,306 0,340 
_Ihosp_id_6 -0,114 0,190 -0,600 0,549 -0,486 0,259 
_Ihosp_id_8 0,135 0,199 0,680 0,497 -0,255 0,526 
_Ihosp_id_9 -0,612 0,210 -2,910 0,004 -1,024 -0,200 
_Ihosp_id_10 0,025 0,189 0,130 0,894 -0,344 0,395 
_Ihosp_id_11 -0,286 0,189 -1,510 0,130 -0,656 0,084 
_Ihosp_id_12 -0,174 0,167 -1,040 0,297 -0,501 0,153 
_Ihosp_id_13 -0,420 0,166 -2,530 0,011 -0,744 -0,095 
_Ihosp_id_14 0,440 0,508 0,860 0,387 -0,557 1,436 
_Ihosp_id_15 -1,011 0,176 -5,750 0,000 -1,356 -0,666 
_Ihosp_id_16 0,017 0,211 0,080 0,934 -0,396 0,430 
_Ihosp_id_17 0,272 0,197 1,380 0,168 -0,115 0,659 
_Ihosp_id_18 0,333 0,166 2,010 0,045 0,008 0,659 
_Ihosp_id_19 0,851 0,188 4,530 0,000 0,483 1,219 
_Ihosp_id_20 -0,347 0,226 -1,540 0,124 -0,791 0,096 
_Ihosp_id_21 0,241 0,177 1,360 0,173 -0,106 0,589 
_Ihosp_id_22 0,236 0,165 1,430 0,152 -0,087 0,559 
_Ihosp_id_23 -0,411 0,243 -1,690 0,090 -0,887 0,065 
_Ihosp_id_24 -0,268 0,166 -1,620 0,106 -0,592 0,057 
_Ihosp_id_25 -0,572 0,267 -2,140 0,032 -1,096 -0,049 
_Ihosp_id_26 0,055 0,194 0,290 0,776 -0,326 0,437 
_Ihosp_id_27 -0,198 0,162 -1,220 0,221 -0,514 0,119 
_cons -3,438 0,823 -4,180 0,000 -5,052 -1,824 
Stats 
Number of obs= 28837 
LR  χ
2
(39) = 673,87 
Prob >  χ
2
 = 0,0000 
Pseudo R2 = 0,0414 
Joint Tests 
year χ
2
 (5) = 4.83 
Prob > χ2 = 0.4373 
hospital χ
2
 (25) =  247.38 
Prob > χ
2
 = 0.0000 
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6. Breakdown: Year 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV05 0,575 0,346 1,660 0,097 -0,103 1,253 
VV06 0,014 0,152 0,090 0,928 -0,284 0,311 
VV07 0,202 0,123 1,640 0,101 -0,039 0,444 
VV08 0,128 0,125 1,020 0,306 -0,117 0,374 
VV09 -0,025 0,128 -0,200 0,842 -0,276 0,225 
Nddx 0,092 0,008 11,490 0,000 0,076 0,107 
sex 0,077 0,044 1,740 0,081 -0,010 0,164 
age -0,029 0,026 -1,130 0,259 -0,079 0,021 
age2 0,056 0,020 2,790 0,005 0,016 0,095 
_Iyear_2005 -0,063 0,077 -0,820 0,411 -0,215 0,088 
_Iyear_2006 -0,037 0,080 -0,460 0,648 -0,194 0,121 
_Iyear_2007 -0,086 0,087 -0,990 0,323 -0,257 0,085 
_Iyear_2008 -0,214 0,101 -2,120 0,034 -0,412 -0,016 
_Iyear_2009 -0,015 0,117 -0,130 0,897 -0,244 0,214 
_Ihosp_id_2 -0,324 0,182 -1,780 0,075 -0,681 0,032 
_Ihosp_id_3 -0,182 0,192 -0,950 0,342 -0,558 0,194 
_Ihosp_id_4 0,336 0,210 1,600 0,110 -0,075 0,747 
_Ihosp_id_5 0,000 0,165 0,000 1,000 -0,323 0,323 
_Ihosp_id_6 -0,120 0,190 -0,630 0,528 -0,493 0,253 
_Ihosp_id_8 0,132 0,200 0,660 0,510 -0,260 0,523 
_Ihosp_id_9 -0,618 0,211 -2,930 0,003 -1,031 -0,205 
_Ihosp_id_10 0,031 0,188 0,170 0,867 -0,337 0,400 
_Ihosp_id_11 -0,323 0,188 -1,720 0,085 -0,691 0,045 
_Ihosp_id_12 -0,155 0,166 -0,930 0,352 -0,481 0,171 
_Ihosp_id_13 -0,410 0,165 -2,480 0,013 -0,734 -0,086 
_Ihosp_id_14 0,435 0,509 0,860 0,392 -0,562 1,432 
_Ihosp_id_15 -1,047 0,176 -5,960 0,000 -1,392 -0,703 
_Ihosp_id_16 0,020 0,211 0,090 0,925 -0,393 0,433 
_Ihosp_id_17 0,272 0,198 1,380 0,168 -0,115 0,660 
_Ihosp_id_18 0,347 0,166 2,090 0,036 0,022 0,672 
_Ihosp_id_19 0,847 0,188 4,510 0,000 0,479 1,216 
_Ihosp_id_20 -0,349 0,226 -1,540 0,123 -0,793 0,094 
_Ihosp_id_21 0,241 0,177 1,360 0,174 -0,107 0,588 
_Ihosp_id_22 0,220 0,165 1,340 0,181 -0,103 0,544 
_Ihosp_id_23 -0,409 0,243 -1,690 0,092 -0,886 0,067 
_Ihosp_id_24 -0,262 0,165 -1,580 0,113 -0,586 0,062 
_Ihosp_id_25 -0,581 0,267 -2,170 0,030 -1,105 -0,057 
_Ihosp_id_26 0,046 0,195 0,240 0,812 -0,336 0,428 
_Ihosp_id_27 -0,197 0,162 -1,220 0,224 -0,514 0,120 
_cons -3,433 0,823 -4,170 0,000 -5,047 -1,819 
Stats 
Number of obs = 28837 
LR  χ
2
(39) = 676.61 
Prob >  χ
2
 = 0,0000 
Pseudo R2 = 0,0416 
Joint Tests 
year χ
2
 (5) = 5.12 
Prob > χ2 = 0.4016 
hospital χ
2
 (25) =  251.13 
Prob > χ
2
 = 0.0000 
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7. Breakdown: Expertise & Year 
DMort Coef. Std. Err. z P>|z| [95% Conf. Interval] 
VV05_01 0,559 0,352 1,590 0,112 -0,130 1,248 
VV06_01 -0,018 0,177 -0,100 0,920 -0,365 0,329 
VV06_02 0,075 0,339 0,220 0,824 -0,589 0,740 
VV07_01 0,184 0,167 1,100 0,271 -0,143 0,511 
VV07_02 0,184 0,171 1,070 0,284 -0,152 0,519 
VV07_03 0,119 0,391 0,300 0,762 -0,648 0,885 
VV08_01 0,018 0,175 0,100 0,920 -0,326 0,361 
VV08_02 0,137 0,177 0,770 0,440 -0,210 0,484 
VV08_03 0,076 0,189 0,400 0,688 -0,295 0,447 
VV08_04 0,498 0,336 1,480 0,138 -0,161 1,157 
VV09_01 0,128 0,161 0,790 0,427 -0,188 0,444 
VV09_02 -0,072 0,177 -0,400 0,686 -0,419 0,275 
VV09_03 -0,134 0,179 -0,750 0,454 -0,485 0,217 
VV09_04 -0,145 0,200 -0,730 0,466 -0,537 0,246 
VV09_05 0,123 0,364 0,340 0,736 -0,590 0,835 
Nddx 0,092 0,008 11,530 0,000 0,077 0,108 
sex 0,078 0,044 1,760 0,079 -0,009 0,165 
age -0,028 0,026 -1,100 0,270 -0,078 0,022 
age2 0,055 0,020 2,760 0,006 0,016 0,094 
_Iyear_2005 -0,063 0,077 -0,820 0,413 -0,214 0,088 
_Iyear_2006 -0,035 0,081 -0,430 0,667 -0,194 0,124 
_Iyear_2007 -0,082 0,088 -0,930 0,351 -0,255 0,090 
_Iyear_2008 -0,203 0,102 -2,000 0,046 -0,402 -0,004 
_Iyear_2009 -0,006 0,117 -0,050 0,962 -0,235 0,224 
_Ihosp_id_2 -0,310 0,192 -1,610 0,106 -0,687 0,066 
_Ihosp_id_3 -0,186 0,192 -0,970 0,332 -0,562 0,190 
_Ihosp_id_4 0,322 0,210 1,530 0,125 -0,089 0,734 
_Ihosp_id_5 0,016 0,168 0,090 0,926 -0,314 0,345 
_Ihosp_id_6 -0,123 0,190 -0,650 0,518 -0,496 0,250 
_Ihosp_id_8 0,130 0,200 0,650 0,516 -0,261 0,521 
_Ihosp_id_9 -0,621 0,211 -2,950 0,003 -1,034 -0,208 
_Ihosp_id_10 0,072 0,193 0,370 0,709 -0,306 0,449 
_Ihosp_id_11 -0,309 0,201 -1,530 0,125 -0,704 0,086 
_Ihosp_id_12 -0,143 0,169 -0,850 0,398 -0,473 0,188 
_Ihosp_id_13 -0,433 0,166 -2,610 0,009 -0,759 -0,107 
_Ihosp_id_14 0,432 0,509 0,850 0,396 -0,565 1,429 
_Ihosp_id_15 -1,030 0,188 -5,470 0,000 -1,399 -0,661 
_Ihosp_id_16 0,019 0,211 0,090 0,928 -0,394 0,432 
_Ihosp_id_17 0,269 0,198 1,360 0,173 -0,118 0,657 
_Ihosp_id_18 0,330 0,166 1,980 0,047 0,004 0,657 
_Ihosp_id_19 0,846 0,188 4,500 0,000 0,477 1,214 
_Ihosp_id_20 -0,353 0,226 -1,560 0,119 -0,797 0,090 
_Ihosp_id_21 0,267 0,179 1,490 0,137 -0,085 0,618 
_Ihosp_id_22 0,242 0,168 1,440 0,150 -0,088 0,571 
_Ihosp_id_23 -0,410 0,243 -1,690 0,091 -0,886 0,066 
_Ihosp_id_24 -0,285 0,166 -1,710 0,087 -0,610 0,041 
_Ihosp_id_25 -0,585 0,267 -2,190 0,029 -1,109 -0,061 
_Ihosp_id_26 0,043 0,195 0,220 0,824 -0,339 0,425 
_Ihosp_id_27 -0,206 0,162 -1,270 0,202 -0,524 0,111 
_cons -3,452 0,824 -4,190 0,000 -5,068 -1,836 
Stats 
Number of obs = 28837 
LR  χ
2
 (49) = 681,60 
Prob >  χ
2
 = 0.0000 
Pseudo R2 = 0,0419 
Joint Tests 
year χ
2
 (5) = 4.68 
Prob > χ
2
 = 0.4559 
hospital χ
2
 (25) =  216.03 
Prob > χ
2
 = 0.0000 
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Appendix 5: Regional Analysis - detailed results 
 
 
 
 
 
 
 
  
Simple Linear Regression 
smr Coef. Std. Err. t P>|t| [95% Conf. Interval] 
_Iregion2 -11,8 4,8 -2,5 0,0 -21,4 -2,3 
_Iregion3 1,2 4,7 0,3 0,8 -8,1 10,6 
_Iregion4 -35,1 4,8 -7,3 0,0 -44,6 -25,6 
_Iregion5 9,5 4,7 2,0 0,0 0,1 18,8 
_Iregion6 -11,4 4,7 -2,4 0,0 -20,8 -2,1 
_Iregion7 -13,3 4,7 -2,8 0,0 -22,6 -3,9 
_Iregion8 -19,0 4,7 -4,0 0,0 -28,3 -9,6 
_Iregion9 -19,7 4,7 -4,2 0,0 -29,1 -10,4 
_Iregion10 -39,5 4,9 -8,1 0,0 -49,2 -29,9 
_Iregion11 -33,1 4,7 -7,0 0,0 -42,5 -23,7 
_Iregion12 -30,4 4,9 -6,2 0,0 -40,0 -20,7 
_Iregion13 -25,4 4,8 -5,3 0,0 -34,8 -16,0 
_Iregion14 -21,8 4,9 -4,5 0,0 -31,4 -12,2 
_Iregion15 -18,5 4,7 -3,9 0,0 -27,8 -9,1 
_Iregion16 28,4 4,7 6,0 0,0 19,0 37,7 
_Iregion17 18,1 4,7 3,8 0,0 8,7 27,5 
_Iregion18 -38,3 4,9 -7,8 0,0 -47,9 -28,7 
_Iregion19 -27,3 4,9 -5,6 0,0 -37,0 -17,7 
_Iregion20 8,9 4,7 1,9 0,1 -0,5 18,2 
_Iregion21 2,1 4,7 0,4 0,7 -7,3 11,4 
_Iregion22 -16,0 4,8 -3,3 0,0 -25,5 -6,5 
_Iregion23 -21,2 4,7 -4,5 0,0 -30,6 -1,2 
_Iregion24 -17,5 4,7 -3,7 0,0 -26,9 -8,2 
_Iyear_2002 -13,2 2,9 -4,5 0,0 -18,9 -7,4 
_Iyear_2003 -16,3 2,9 -5,6 0,0 -22,1 -10,6 
_Iyear_2004 -31,1 2,9 -10,7 0,0 -36,8 -25,4 
_Iyear_2005 -38,1 2,9 -13,1 0,0 -43,8 -32,4 
_Iyear_2006 -52,2 3,0 -17,7 0,0 -58,0 -46,3 
_Iyear_2007 -48,6 3,0 -16,0 0,0 -54,6 -42,6 
_Iyear_2008 -53,5 3,1 -17,4 0,0 -59,6 -47,5 
_Iyear_2009 -60,1 3,4 -17,6 0,0 -66,8 -53,4 
VV 2,7 2,7 1,0 0,3 -2,6 8,0 
_cons 148,2 3,9 38,0 0,0 140,5 155,8 
Stats 
Number of obs = 216 
F( 32,183) = 45,14 
Prob > F =  0,0000 
Adj R-squared = 0,8679 
Joint Tests 
region F (23, 183) = 26,33 
P > F =0.000 
year F (8, 183) = 75,27  
P > F =0.000 
 Program “Via Verde do AVC” - Analysis of the Impact on Stroke Mortality  
Sara Sofia Silvestre Silva 
 
42 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Population-weighted Linear Regression 
smr Coef. Std. Err. t P>|t| [95% Conf. Interval] 
_Iregion2 -12,4 4,6 -2,7 0,0 -21,5 -3,2 
_Iregion3 1,2 4,1 0,3 0,8 -6,9 9,2 
_Iregion4 -35,5 4,1 -8,7 0,0 -43,6 -27,5 
_Iregion5 9,3 5,2 1,8 0,1 -0,9 19,6 
_Iregion6 -11,6 3,9 -3,0 0,0 -19,3 -3,9 
_Iregion7 -13,2 4,6 -2,9 0,0 -22,3 -4,2 
_Iregion8 -19,0 4,3 -4,4 0,0 -27,6 -10,5 
_Iregion9 -19,7 4,2 -4,7 0,0 -28,0 -11,3 
_Iregion10 -40,0 4,5 -8,9 0,0 -48,9 -31,2 
_Iregion11 -33,2 4,0 -8,3 0,0 -41,1 -25,3 
_Iregion12 -31,6 3,8 -8,3 0,0 -39,1 -24,1 
_Iregion13 -25,7 3,4 -7,5 0,0 -32,4 -18,9 
_Iregion14 -22,3 4,2 -5,4 0,0 -30,6 -14,1 
_Iregion15 -18,4 4,9 -3,8 0,0 -28,1 -8,7 
_Iregion16 28,0 4,1 6,9 0,0 19,9 36,0 
_Iregion17 17,9 4,0 4,5 0,0 10,1 25,8 
_Iregion18 -39,0 4,2 -9,3 0,0 -47,3 -30,7 
_Iregion19 -27,9 4,7 -6,0 0,0 -37,1 -18,7 
_Iregion20 8,7 3,9 2,3 0,0 1,1 16,4 
_Iregion21 2,1 5,2 0,4 0,7 -8,2 12,5 
_Iregion22 -16,5 4,4 -3,7 0,0 -25,2 -7,7 
_Iregion23 -21,3 5,1 -4,1 0,0 -31,5 -11,2 
_Iregion24 -17,7 4,1 -4,3 0,0 -25,8 -9,5 
_Iyear_2002 -14,0 2,8 -5,0 0,0 -19,5 -8,4 
_Iyear_2003 -16,9 2,8 -6,0 0,0 -22,5 -11,4 
_Iyear_2004 -31,7 2,8 -11,3 0,0 -37,3 -26,2 
_Iyear_2005 -38,5 2,8 -13,7 0,0 -44,0 -32,9 
_Iyear_2006 -52,9 2,9 -18,5 0,0 -58,6 -47,3 
_Iyear_2007 -49,1 2,9 -16,7 0,0 -54,9 -43,4 
_Iyear_2008 -55,4 3,0 -18,4 0,0 -61,4 -49,5 
_Iyear_2009 -60,7 3,4 -18,0 0,0 -67,4 -54,1 
VV 4,1 2,6 1,6 0,1 -1,1 9,2 
_cons 148,8 3,2 46,5 0,0 142,5 155,2 
Stats 
Number of obs = 216 
F( 32,183) = 48,96 
Prob > F =  0,0000 
Adj R-squared = 0,8771 
Joint Tests 
region F (23, 183) =  
P > F =0.000 
year F (8, 183) =  
P > F =0.000 
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